Skip to content
lifestyle.mmminimal.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Aclarion, Inc.
Aclarion Rejects Echo Lake Capital’s Unsolicited Acquisition Proposal
June 8, 2026
Aclarion Stockholders Approve All Proposals at 2026 Annual Meeting
June 8, 2026
Aclarion Adds Institute of Neuro Innovation to Support Nociscan Growth and Real-World Evidence Generation
June 3, 2026
Aclarion Technology Demonstrates Potential Beyond Surgical Planning in New Immune-Biomarker Study
June 1, 2026
Aclarion, Inc. Comments on Echo Lake Capital’s Letter and Unsolicited Proposal
May 28, 2026
Aclarion Announces Addition of First Private Practice Site in Los Angeles into CLARITY Trial to Further Accelerate Enrollment
May 7, 2026
Aclarion Announces Inducement Grant to New Commercial Director, Western U.S.
May 6, 2026
Aclarion Announces Second Commercial Agreement with Weill Cornell Medicine
May 5, 2026
Aclarion Delivers Strong Q1 2026 Results with 196% Annual Scan Volume Growth Reflecting Accelerating Clinical Adoption
April 30, 2026
Aclarion Appoints Daniel Keefe as Commercial Director, Western U.S., to Drive Continued Adoption of Nociscan
April 28, 2026
1
2
3
Next Page
→